Detalles de la búsqueda
1.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol;
164(2): 428-436, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903380
2.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Gynecol Oncol;
160(1): 244-251, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109392
3.
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Gynecol Oncol;
156(1): 131-139, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31759774
4.
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
Int J Gynecol Cancer;
30(5): 596-601, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32114513
5.
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Support Care Cancer;
27(2): 531-538, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30003341
6.
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Lancet Oncol;
19(8): 1126-1134, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026002
7.
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Lancet Oncol;
16(3): 301-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638326
8.
Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol;
136(2): 323-7, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25529832
9.
Attitudes of physicians and patients toward immediate and intraoperative chemotherapy treatment in colon cancer.
Cancer Treat Res Commun;
39: 100798, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447475
10.
The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.
Gynecol Oncol;
124(3): 379-82, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22119995
11.
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
J Clin Oncol;
40(13): 1464-1473, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130043
12.
Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected].
Clin Cancer Res;
14(7): 2111-8, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18381952
13.
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study.
Genet Med;
9(10): 705-12, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18073584
14.
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
Gynecol Oncol;
107(2): 173-6, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17950384
15.
Survivorship as an element of clinical trials in ovarian cancer.
Int J Gynecol Cancer;
21(4): 788-92, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21543942
16.
Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Int J Gynaecol Obstet;
95 Suppl 1: S247-57, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17161164
17.
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.
J Clin Oncol;
21(5): 836-42, 2003 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12610182
18.
Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer.
Expert Rev Pharmacoecon Outcomes Res;
12(3): 279-81, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22812551
19.
Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention.
Cancer Prev Res (Phila);
5(10): 1173-82, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22827974
20.
Supportive care for women with gynecologic cancers.
Expert Rev Anticancer Ther;
8(2): 227-41, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18279064